Ogbuagu O, Molina JM, Chetchotisakd P, Ramgopal MN, et al. Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multi-Drug Resistant HIV-1: Week 104 Results of a Phase 2/3 Trial. Clin Infect Dis 2024 Aug 29:ciae423. doi: 10.1093.
PMID: 39206943